Macroaxis: Personalized Investing

Personalized Investing and

Digital Wealth Optimization

NVO    AGN    TEVA    ENDP    Benchmark  United States  NYSE  10,875   9.9912 Index Moved Up 0.092%  

Processing. Please wait...

Amarin Probability Of Bankruptcy  

$2.41  0.15  6.64%     
For stocks, Probability Of Bankruptcy is normalized value of Z-Score. For funds and ETFs it is derived from a multi-factor model developed by Macroaxis.The score is used to predict probability of a firm or a fund going into bankruptcy or experiencing financial distress within next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100 indicating the actual probability the firm will be distressed in the next 2 fiscal years.
Probability Of Bankruptcy 
93.77 %

About Probability Of Bankruptcy

Companies or funds with Probability Of Bankruptcy above 90% are generally considered to be high risk with a good chance of bankruptcy in the next 2 years. On the other hand entities with Probability Of Bankruptcy of less than 15% will most likely experience some growth in the next 2 years. Probability Of Bankruptcy is based on Macroaxis own algorithm and can be used by auditors, accountants, money managers, financial advisers, as well as day traders to evaluate unsystematic risk of a stock, fund or ETF.
Compare Amarin to competition

Amarin Probability Of Bankruptcy Assessment

Benchmark  Embed   Amarin Comparables 
Based on latest financial disclosure Amarin Corporation plc has Probability Of Bankruptcy of 93%. This is 131.76% higher than that of the Healthcare sector, and 56.68% higher than that of Drug Manufacturers - Other industry, The Probability Of Bankruptcy for all stocks is 118.12% lower than the firm.

Filter other Stocks by Probability Of Bankruptcy

Select Probability Of Bankruptcy Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
Found 10 equities

Probability Of Bankruptcy

NVO NYQNovo Nordisk AS
AGN NYQAllergan Inc
TEVA NYQTeva Pharmaceutical Industries Limited
ENDP NMSEndo International plc
RDY NYQDr Reddys Laboratories Ltd
ISIS NMSIsis Pharmaceuticals Inc
UTHR NMSUnited Therapeutics Corporation
TARO NYQTaro Pharmaceutical Industries Ltd
OREX NMSOrexigen Therapeutics Inc
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Amarin Corporation plc has more than 93 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
NameAmarin Corporation plc
InstrumentUSA Stock
CurrencyUSD - US Dollar
ExchangeNASDAQ General Markets

Other Amarin Fundamentals

Return On Asset(28.32) %
Profit Margin(103.99) %
Operating Margin(177.03) %
Current Valuation108.86 M
Shares Outstanding865 K
Shares Owned by Insiders3.93 %
Shares Owned by Institutions33.30 %
Number of Shares Shorted26.58 M
Price to Earning291.00 times
Price to Book341.94 times
Price to Sales0.03 times
Revenue54.2 M
Gross Profit14.44 M
EBITDA(95.11 M)
Net Income(56.36 M)
Cash and Equivalents119.54 M
Cash per Share138.05 times
Total Debt226.86 M
Current Ratio3.60 times
Book Value Per Share(0.51) times
Cash Flow from Operations(72.31 M)
Short Ratio22.90 times
One Year High2.09
One Year Low0.78
Earnings Per Share(0.36) times
Price to Earnings To Growth(0.06) times
Number of Employees185
Market Capitalization1.54 M
Total Asset185.37 M
Retained Earnings(950.58 M)
Working Capital122.7 M
Current Asset158.04 M
Current Liabilities35.34 M
Z Score-7.0